Shamim Ruff, SVP, Regulatory Affairs & Qual at Sarepta Therapeutics, Inc. (SRPT), sold 12,138 shares at $42.00 ($522K) on 2017-07-20, disclosed to the SEC on 2017-07-21.
Open-market sale of $522k SRPT by SVP, Regulatory Affairs & Qual. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.00 | 6,250 | $263K | 50.3% |
| 2 | $44.00 | 1,500 | $66K | 12.7% |
| 3 | $44.00 | 4,388 | $193K | 37.0% |
| Total | $42.97 avg | 12,138 | $522K | 100% |
| Filing → |
| SRPT | SELL | 2017-11-08 | $550K | — | Filing → |
| SRPT | SELL | 2017-10-05 | $575K | — | Filing → |
| SRPT | SELL | 2016-09-30 | $439K | — | Filing → |